Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cancers associated with AIDS]

P Piedbois, H Frikha, J P Le Bourgeois

    Bulletin Du Cancer. Radiotherapie : Journal De La Societe Francaise Du Cancer : Organe De La Societe Francaise De Radiotherapie Oncologique
    |January 1, 1995
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    STSM 2025 & 2nd African Medical Writing Congress.

    La Tunisie medicale·2026
    Same author

    2022 TUNISIAN NATIONAL CONGRESS OF MEDICINE ABSTRACTS.

    La Tunisie medicale·2023
    Same author

    Postoperative irinotecan in resected stage II-III rectal cancer: final analysis of the French R98 Intergroup trial†.

    Annals of oncology : official journal of the European Society for Medical Oncology·2015
    Same author

    A phase III adjuvant randomised trial of 6 cycles of 5-fluorouracil-epirubicine-cyclophosphamide (FEC100) versus 4 FEC 100 followed by 4 Taxol (FEC-T) in node positive breast cancer patients (Trial B2000).

    European journal of cancer (Oxford, England : 1990)·2013
    Same author

    [Phyllodes tumors and breast sarcomas: a review].

    Bulletin du cancer·2010
    Same author

    [Cost effectiveness analysis of screening strategies for cervical cancer in Tunisia].

    Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit·2010
    Same journal

    [Evaluation and quality assurance of equipment in radiation oncology].

    Bulletin du cancer. Radiotherapie : journal de la Societe francaise du cancer : organe de la societe francaise de radiotherapie oncologique·1996
    Same journal

    [Portal imaging: the legal point of view].

    Bulletin du cancer. Radiotherapie : journal de la Societe francaise du cancer : organe de la societe francaise de radiotherapie oncologique·1996
    Same journal

    [Quality control in electronic portal imaging devices. Commission Imagerie, Société française des physiciens d'hôpital].

    Bulletin du cancer. Radiotherapie : journal de la Societe francaise du cancer : organe de la societe francaise de radiotherapie oncologique·1996
    Same journal

    [Current clinical practice of real time electronic portal imaging in France].

    Bulletin du cancer. Radiotherapie : journal de la Societe francaise du cancer : organe de la societe francaise de radiotherapie oncologique·1996
    Same journal

    Clinical implementation of electronic portal imaging: correction strategies and set-up errors.

    Bulletin du cancer. Radiotherapie : journal de la Societe francaise du cancer : organe de la societe francaise de radiotherapie oncologique·1996
    Same journal

    [Portal imaging. State of the art in 1996].

    Bulletin du cancer. Radiotherapie : journal de la Societe francaise du cancer : organe de la societe francaise de radiotherapie oncologique·1996
    See all related articles

    The acquired immunodeficiency syndrome (AIDS) defining conditions now include Kaposi

    Area of Science:

    • Oncology
    • Immunology
    • Virology

    Background:

    • Acquired immunodeficiency syndrome (AIDS) defining conditions expanded to include epidemic Kaposi's sarcoma (1981), high/intermediate grade lymphoma (1985), and cervical carcinoma (1993).
    • Understanding the pathogenesis and natural history of these AIDS-defining malignancies is crucial for effective management.

    Discussion:

    • Treatment strategies for AIDS-defining neoplasms must account for the patient's immunocompromised status.
    • The clinical course of AIDS, including opportunistic infections, significantly impacts treatment decisions and patient outcomes.

    Key Insights:

    • The inclusion of specific malignancies as AIDS-defining conditions reflects evolving understanding of HIV-related cancers.
    • Multidisciplinary approaches are essential for managing complex oncological and immunological challenges in AIDS patients.

    Related Experiment Videos

    Outlook:

    • Continued research into the pathogenesis of AIDS-defining cancers may reveal novel therapeutic targets.
    • Advances in antiretroviral therapy and cancer treatment hold promise for improving survival and quality of life for individuals with AIDS.